Position
Squarepoint Ops LLC in Tango Therapeutics, Inc.
Back to the book · All holders of TNGX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.1M$8.86 → $20.92
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 173.9K | $1.54M | — | — | — | 0.0% |
| Q1 2026 | 178.9K | $3.74M | $20.92 | $2.1M | $104.2K | 0.0% |